The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

A growing number of people are turning to medications like Ozempic, Wegovy, and Mounjaro to aid in weight loss and manage ...

Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...

Specific sales figures for Wegovy and Ozempic were not disclosed, but competition from Lilly’s Mounjaro, which reported $3.8 ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

With millions of Brits on weight-loss injections, those taking them have been urged to consider how they will travel with the ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...